– USA, MA – PathMaker Neurosystems Inc., a clinical-stage neuromodulation company developing breakthrough non-invasive technology for the treatment of patients with serious neurological disorders such as stroke, amyotrophic lateral sclerosis and spinal cord injury, appointed Terri Bresenham to its Board of Directors.…
– USA, MA – AlloVir, a late clinical-stage cell therapy company, today announced the addition of Dr.…
– USA, MA – Scholar Rock (NASDAQ: SRRK), a clinical-stage biopharmaceutical company focused on the treatment of serious diseases in which protein growth factors play a fundamental role, today announced the appointment of Tony Kingsley as president and CEO, effective August 1, 2020.…
– SWITZERLAND, Geneva – iOnctura SA, a clinical-stage biopharmaceutical company, developing a pipeline of next-generation molecules targeting cancer and fibrosis, today announced that it has raised an additional EUR 5.1 million bringing the total Series A financing to EUR 20.1 million.…
– USA, CA – Vir Biotechnology, Inc. (Nasdaq: VIR) today announced the appointment of Dr Elliott Sigal, M.D.,…